Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
Author:
Leisl M. Packer,Sareena Rana,Robert Hayward,Thomas O'Hare,Christopher A. Eide,Ana Rebocho,Sonja Heidorn,Matthew S. Zabriskie,Ion Niculescu-Duvaz,Brian J. Druker,Caroline Springer,Richard Marais
Copyright © 2011 Elsevier Inc. All rights reserved.